View in EDS HTML Full Text PDF Full Text

Rare mutation-dominant compound EGFR-positive NSCLC is associated with enriched kinase domain-resided variants of uncertain significance and poor clinical outcomes.

Saved in:

Bibliographic Details
Title:	Rare mutation-dominant compound EGFR-positive NSCLC is associated with enriched kinase domain-resided variants of uncertain significance and poor clinical outcomes.
Authors:	Zhao, Weixin^1,2,3 (AUTHOR), Song, Ailing⁴ (AUTHOR), Xu, Yang⁵ (AUTHOR), Wu, Qian⁵ (AUTHOR), Liu, Cuicui⁵ (AUTHOR), Yin, Jiani C.⁵ (AUTHOR), Ou, Qiuxiang⁵ (AUTHOR), Wu, Xue⁵ (AUTHOR), Shao, Yang^5,6 (AUTHOR), Zhao, Xinmin^2,7 (AUTHOR) mizuyiaaa@163.com
Source:	BMC Medicine. 2/24/2023, Vol. 21 Issue 1, p1-16. 16p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	17417015
DOI:	10.1186/s12916-023-02768-z